Viking Surges 342% in the Past Year: How Should You Play the Stock? [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
The upside was triggered by positive updates on its pipeline programs for obesity and non-alcoholic steatohepatitis (NASH) indications. Based on the encouraging results, management intends to meet with the FDA to discuss the late-stage study design and timings for both programs. In the past year, the stock has significantly outperformed the industry's 2.5% decline. The stock has outperformed the sector and the S&P 500 during the same period. VKTX's shares are also trading above the 50-day and 200-day moving averages. VKTX Stock Outperforms Industry, Sector & S&P 500 Image Source: Zacks Investment Research Let's take a brief look at the factors governing the company's prospects. Market Potential for VKTX's Drug in the Obesity Space The obesity market has garnered much interest lately, with two companies — Eli Lilly LLY and Novo Nordisk NVO — dominating this space with their respective obesity drugs Zepbound and Wegovy. Despite having approved drugs in this space, LLY and
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now. [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735 [Yahoo! Finance]Yahoo! Finance
- Why Investors Plowed Into Viking Therapeutics Stock Today [Yahoo! Finance]Yahoo! Finance
- Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic? [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $105.00 price target on the stock.MarketBeat
VKTX
Earnings
- 7/24/24 - Beat
VKTX
Sec Filings
- 8/22/24 - Form 4
- 8/22/24 - Form 4
- 8/21/24 - Form 144
- VKTX's page on the SEC website